No abstract available
MeSH terms
-
Anticoagulants / therapeutic use
-
Cost of Illness
-
Health Care Costs
-
Humans
-
Incidence
-
Platelet Aggregation Inhibitors / therapeutic use
-
Practice Guidelines as Topic
-
Prevalence
-
Recovery of Function
-
Risk Assessment
-
Risk Factors
-
Secondary Prevention
-
Stroke / economics
-
Stroke / etiology
-
Stroke / mortality
-
Stroke / physiopathology
-
Stroke / prevention & control*
-
United States / epidemiology
-
Vascular Surgical Procedures
Substances
-
Anticoagulants
-
Platelet Aggregation Inhibitors